CSN5/Jab1 Is Involved in Ligand-Dependent Degradation of Estrogen Receptor α by the Proteasome

REFERENCES

• Alarid, E. T., N. Bakopoulos, and N. Solodin. 1999. Proteasome-mediated proteolysis of estrogen receptor: a novel component in autologous down-regulation. Mol. Endocrinol. 13:1522–1534.
   PubMed Web of Science ®Google Scholar
• Arnold, S. F., J. D. Obourn, H. Jaffe, and A. C. Notides. 1995. Phosphorylation of the human estrogen receptor by mitogen-activated protein kinase and casein kinase II: consequence on DNA binding. J. Steroid Biochem. Mol. Biol. 55:163–172.
   PubMed Web of Science ®Google Scholar
• Balaguer, P., A. M. Boussioux, E. Demirpence, and J. C. Nicolas. 2001. Reporter cell lines are useful tools for monitoring biological activity of nuclear receptor ligands. Luminescence 16:153–158.
   PubMed Web of Science ®Google Scholar
• Bech-Otschir, D., R. Kraft, X. Huang, P. Henklein, B. Kapelari, C. Pollmann, and W. Dubiel. 2001. COP9 signalosome-specific phosphorylation targets p53 to degradation by the ubiquitin system. EMBO J. 20:1630–1639.
   PubMed Web of Science ®Google Scholar
• Bianchi, E., S. Denti, A. Granata, G. Bossi, J. Geginat, A. Villa, L. Rogge, and R. Pardi. 2000. Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity. Nature 404:617–621.
   PubMed Web of Science ®Google Scholar
• Chauchereau, A., M. Georgiakaki, M. Perrin-Wolff, E. Milgrom, and H. Loosfelt. 2000. JAB1 interacts with both the progesterone receptor and SRC-1. J. Biol. Chem. 275:8540–8548.
   PubMedGoogle Scholar
• Chen, D., T. Riedl, E. Washbrook, P. E. Pace, R. C. Coombes, J. M. Egly, and S. Ali. 2000. Activation of estrogen receptor alpha by S118 phosphorylation involves a ligand-dependent interaction with TFIIH and participation of CDK7. Mol. Cell 6:127–137.
   PubMed Web of Science ®Google Scholar
• Cope, G. A., and R. J. Deshaies. 2003. COP9 signalosome: a multifunctional regulator of SCF and other cullin-based ubiquitin ligases. Cell 114:663–671.
   PubMed Web of Science ®Google Scholar
• Fan, M., R. M. Bigsby, and K. P. Nephew. 2003. The NEDD8 pathway is required for proteasome-mediated degradation of human estrogen receptor (ER)-α and essential for the antiproliferative activity of ICI 182,780 in ERα-positive breast cancer cells. Mol. Endocrinol. 17:356–365.
   PubMed Web of Science ®Google Scholar
• Fan, M., X. Long, J. A. Bailey, C. A. Reed, E. Osborne, E. A. Gize, E. A. Kirk, R. M. Bigsby, and K. P. Nephew. 2002. The activating enzyme of NEDD8 inhibits steroid receptor function. Mol. Endocrinol. 16:315–330.
   PubMedGoogle Scholar
• Fan, M., H. Nakshatri, and K. P. Nephew. 2004. Inhibiting proteasomal proteolysis sustains estrogen receptor-α activation. Mol. Endocrinol. 18:2603–2615.
   PubMedGoogle Scholar
• Giamarchi, C., C. Chailleux, M. Callige, P. Rochaix, D. Trouche, and H. Richard-Foy. 2002. Two antiestrogens affect differently chromatin remodeling of trefoil factor 1 (pS2) gene and the fate of estrogen receptor in MCF7 cells. Biochim. Biophys. Acta 1578:12–20.
   PubMedGoogle Scholar
• Harari-Steinberg, O., and D. A. Chamovitz. 2004. The COP9 signalosome: mediating between kinase signaling and protein degradation. Curr. Protein Pept. Sci. 5:185–189.
   PubMed Web of Science ®Google Scholar
• Jordan, V. C., M. E. Lieberman, E. Cormier, R. Koch, J. R. Bagley, and P. C. Ruenitz. 1984. Structural requirements for the pharmacological activity of nonsteroidal antiestrogens in vitro. Mol. Pharmacol. 26:272–278.
   PubMedGoogle Scholar
• Kim, B. C., H. J. Lee, S. H. Park, S. R. Lee, T. S. Karpova, J. G. McNally, A. Felici, D. K. Lee, and S. J. Kim. 2004. Jab1/CSN5, a component of the COP9 signalosome, regulates transforming growth factor beta signaling by binding to Smad7 and promoting its degradation. Mol. Cell. Biol. 24:2251–2262.
   PubMed Web of Science ®Google Scholar
• Lannigan, D. A. 2003. Estrogen receptor phosphorylation. Steroids 68:1–9.
   PubMed Web of Science ®Google Scholar
• Lonard, D. M., Z. Nawaz, C. L. Smith, and B. W. O'Malley. 2000. The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol. Cell 5:939–948.
   PubMed Web of Science ®Google Scholar
• Lyapina, S., G. Cope, A. Shevchenko, G. Serino, T. Tsuge, C. Zhou, D. A. Wolf, N. Wei, and R. J. Deshaies. 2001. Promotion of NEDD-CUL1 conjugate cleavage by COP9 signalosome. Science 292:1382–1385.
   PubMed Web of Science ®Google Scholar
• Marsaud, V., A. Gougelet, S. Maillard, and J. M. Renoir. 2003. Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERα), differentially affect ERα extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells. Mol. Endocrinol. 17:2013–2027.
   PubMed Web of Science ®Google Scholar
• Metivier, R., A. Stark, G. Flouriot, M. R. Hubner, H. Brand, G. Penot, D. Manu, S. Denger, G. Reid, M. Kos, R. B. Russell, O. Kah, F. Pakdel, and F. Gannon. 2002. A dynamic structural model for estrogen receptor-alpha activation by ligands, emphasizing the role of interactions between distant A and E domains. Mol. Cell 10:1019–1032.
   PubMed Web of Science ®Google Scholar
• Metzger, D., M. Berry, S. Ali, and P. Chambon. 1995. Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol. Endocrinol. 9:579–591.
   PubMed Web of Science ®Google Scholar
• Naumann, M., D. Bech-Otschir, X. Huang, K. Ferrell, and W. Dubiel. 1999. COP9 signalosome-directed c-Jun activation/stabilization is independent of JNK. J. Biol. Chem. 274:35297–35300.
   PubMed Web of Science ®Google Scholar
• Ohh, M., W. Y. Kim, J. J. Moslehi, Y. Chen, V. Chau, M. A. Read, and W. G. Kaelin, Jr. 2002. An intact NEDD8 pathway is required for Cullin-dependent ubiquitylation in mammalian cells. EMBO Rep. 3:177–182.
   PubMed Web of Science ®Google Scholar
• Reid, G., S. Denger, M. Kos, and F. Gannon. 2002. Human estrogen receptor-alpha: regulation by synthesis, modification and degradation. Cell. Mol. Life Sci. 59:821–831.
   PubMed Web of Science ®Google Scholar
• Reid, G., M. R. Hubner, R. Metivier, H. Brand, S. Denger, D. Manu, J. Beaudouin, J. Ellenberg, and F. Gannon. 2003. Cyclic, proteasome-mediated turnover of unliganded and liganded ERα on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11:695–707.
   PubMed Web of Science ®Google Scholar
• Schaffner, W., and C. Weissmann. 1973. A rapid, sensitive, and specific method for the determination of protein in dilute solution. Anal. Biochem. 56:502–514.
   PubMed Web of Science ®Google Scholar
• Schwechheimer, C., and X. W. Deng. 2001. COP9 signalosome revisited: a novel mediator of protein degradation. Trends Cell Biol. 11:420–426.
   PubMed Web of Science ®Google Scholar
• Shang, Y., X. Hu, J. DiRenzo, M. A. Lazar, and M. Brown. 2000. Cofactor dynamics and sufficiency in estrogen receptor-regulated transcription. Cell 103:843–852.
   PubMed Web of Science ®Google Scholar
• Shao, W., E. K. Keeton, D. P. McDonnell, and M. Brown. 2004. Coactivator AIB1 links estrogen receptor transcriptional activity and stability. Proc. Natl. Acad. Sci. USA 101:11599–11604.
   PubMedGoogle Scholar
• Stenoien, D. L., K. Patel, M. G. Mancini, M. Dutertre, C. L. Smith, B. W. O'Malley, and M. A. Mancini. 2001. FRAP reveals that mobility of oestrogen receptor-alpha is ligand- and proteasome-dependent. Nat. Cell Biol. 3:15–23.
   PubMed Web of Science ®Google Scholar
• Sun, Y., M. P. Wilson, and P. W. Majerus. 2002. Inositol 1,3,4-trisphosphate 5/6-kinase associates with the COP9 signalosome by binding to CSN1. J. Biol. Chem. 277:45759–45764.
   PubMed Web of Science ®Google Scholar
• Thompson, E. W., D. Katz, T. B. Shima, A. E. Wakeling, M. E. Lippman, and R. B. Dickson. 1989. ICI 164,384, a pure antagonist of estrogen-stimulated MCF-7 cell proliferation and invasiveness. Cancer Res. 49:6929–6934.
   PubMed Web of Science ®Google Scholar
• Tomoda, K., Y. Kubota, Y. Arata, S. Mori, M. Maeda, T. Tanaka, M. Yoshida, N. Yoneda-Kato, and J. Y. Kato. 2002. The cytoplasmic shuttling and subsequent degradation of p27Kip1 mediated by Jab1/CSN5 and the COP9 signalosome complex. J. Biol. Chem. 277:2302–2310.
   PubMed Web of Science ®Google Scholar
• Tomoda, K., Y. Kubota, and J. Kato. 1999. Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1. Nature 398:160–165.
   PubMed Web of Science ®Google Scholar
• Uhle, S., O. Medalia, R. Waldron, R. Dumdey, P. Henklein, D. Bech-Otschir, X. Huang, M. Berse, J. Sperling, R. Schade, and W. Dubiel. 2003. Protein kinase CK2 and protein kinase D are associated with the COP9 signalosome. EMBO J. 22:1302–1312.
   PubMed Web of Science ®Google Scholar
• Wijayaratne, A. L., and D. P. McDonnell. 2001. The human estrogen receptor-alpha is a ubiquitinated protein whose stability is affected differentially by agonists, antagonists, and selective estrogen receptor modulators. J. Biol. Chem. 276:35684–35692.
   PubMed Web of Science ®Google Scholar
• Wijayaratne, A. L., S. C. Nagel, L. A. Paige, D. J. Christensen, J. D. Norris, D. M. Fowlkes, and D. P. McDonnell. 1999. Comparative analyses of mechanistic differences among antiestrogens. Endocrinology 140:5828–5840.
   PubMed Web of Science ®Google Scholar
• Wolf, D. A., C. Zhou, and S. Wee. 2003. The COP9 signalosome: an assembly and maintenance platform for cullin ubiquitin ligases. Nat. Cell Biol. 5:1029–1033.
   PubMed Web of Science ®Google Scholar
• Wu, R. C., J. Qin, P. Yi, J. Wong, S. Y. Tsai, M. J. Tsai, and B. W. O'Malley. 2004. Selective phosphorylations of the SRC-3/AIB1 coactivator integrate genomic reponses to multiple cellular signaling pathways. Mol. Cell 15:937–949.
   PubMed Web of Science ®Google Scholar
• Zhou, C., V. Seibert, R. Geyer, E. Rhee, S. Lyapina, G. Cope, R. J. Deshaies, and D. A. Wolf. 2001. The fission yeast COP9/signalosome is involved in cullin modification by ubiquitin-related Ned8p. BMC Biochem. 2:7.
   PubMedGoogle Scholar